Minerva Batugo

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics

Peter S. Dragovich, Thomas J. Prins, Ru Zhou et al. · Journal of Medicinal Chemistry · 2002 · 140 citations · Full text

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 8. Pharmacological Optimization of Orally Bioavailable 2-Pyridone-Containing Peptidomimetics

Peter S. Dragovich, Thomas J. Prins, Ru Zhou et al. · Journal of Medicinal Chemistry · 2003 · 113 citations

Pharmacotherapy, Antiviral Drug, Molecular Pharmacology +17

Characterization of Human Corneal Epithelial Cell Model As a Surrogate for Corneal Permeability Assessment: Metabolism and Transport

Cathie Xiang, Minerva Batugo, David C. Gale et al. · Drug Metabolism and Disposition · 2009 · 70 citations

A Novel Nitric Oxide Releasing Prostaglandin Analog, NCX 125, Reduces Intraocular Pressure in Rabbit, Dog, and Primate Models of Glaucoma

Valentina Borghi, Elena Bastia, Massimiliano Guzzetta et al. · Journal of Ocular Pharmacology and Therapeutics · 2010 · 69 citations

Discovery Pharmacokinetic Studies in Mice Using Serial Microsampling, Dried Blood Spots And Microbore Lc–MS/MS

Sadayappan V. Rahavendran, Sylvia Vekich, Heather Skor et al. · Bioanalysis · 2012 · 48 citations